Hostname: page-component-74656f9884-c52kr Total loading time: 0 Render date: 2026-11-09T02:14:15.877Z Has data issue: false hasContentIssue false

Drug–matrix interactions in nanostructured materials containing fluoxetine using sol-gel titanium oxide as a matrix

Published online by Cambridge University Press:  13 September 2011

Mayra González*
Affiliation:
Engineering and Chemical Research Center, C.P. 10600, C. Havana City, Cuba; and Polymer Lab, Institute of Materials Science and Technology, University of Havana, C.P. 10400, C. Havana City, Cuba
Jacques Rieumont
Affiliation:
Department of Physical Chemistry, Faculty of Chemistry, University of Havana, C.P. 10600, Havana City, Cuba
Francois Figueras
Affiliation:
Institut de Recherche sur la Catalyse et l’Environnement de Lyon, UMR 5256, Villeurbanne, France
Patricia Quintana
Affiliation:
Department of Applied Physics, CINVESTAV-IPN, Mérida, A.P. 73, Cordemex, C.P. 97310, Mérida, Yucatán, México
*
a)Address all correspondence to this author. e-mail: mayra.hurtado@infomed.sld.cu

Abstract

Titanium oxide matrix was prepared by sol-gel adding fluoxetine [Prozac (C17H18NF3O)] during the reaction of gelation. This nanostructured material was studied by Fourier transform infrared (FTIR) spectroscopy, N2 adsorption, and x-ray diffraction to detect the interaction between the drug and the matrix. The complex nature of FTIR signals for the matrix and the drug did not allow observation of the interactions; however, using the density functional theory formalism, two stable complexes are suggested to be formed on the drug–matrix system. Both complexes are formed through H bond interactions involving the amine group in fluoxetine and the hydroxylated sites in titanium xerogel. They were found to be energetically stable and independent of the titanium model core cluster used in the calculations.

Information

Type
Articles
Copyright
Copyright © Materials Research Society 2011
Figure 0

FIG. 1. Chemical formula of fluoxetine.

Figure 1

FIG. 2. Scanning electron micrographs of the nanostructured materials containing fluoxetine and hydroxylated titanium oxide matrix (TiO2(OH)/Fx).

Figure 2

FIG. 3. X-ray diffraction pattern of TiO2(OH) matrix, fluoxetine (Fx) drug, and the nanostructured materials (TiO2(OH)/Fx).

Figure 3

FIG. 4. FTIR spectrum of the nanostructured materials TiO2(OH)/Fx, fluoxetine (Fx) drug, and the TiO2(OH) matrix.

Figure 4

TABLE I. Specific surface area, pore volume, and pore diameter obtained by BET (Brunauer-Emmett-Teller) analysis.

Figure 5

FIG. 5. Nitrogen isotherm of the nanostructured materials containing fluoxetine and hydroxylated titanium oxide matrix (TiO2(OH)/Fx).

Figure 6

FIG. 6. Optimized geometries of hydroxylated titanium models. Gray atoms: titanium; red atoms: oxygen.

Figure 7

FIG. 7. Atoms numbering for fluoxetine. Red atoms: oxygen; blue atoms: nitrogen; clear blue atoms: fluoxetine; gray atoms: carbon; clear gray atoms: hydrogen.

Figure 8

TABLE II. Electrophilic Fukui functions for fluoxetine.

Figure 9

FIG. 8. Optimized geometries of fluoxetine–titanium complexes. Red atoms: oxygen, blue atoms: nitrogen, clear blue atoms: fluoxetine.

Figure 10

TABLE III. Enthalpies and Gibbs free energies of reaction (kcal/mol) for the complex formation.